{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:40:18Z","timestamp":1755794418766,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.7759\/cureus.90179","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T21:01:49Z","timestamp":1755291709000},"source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Outcomes Following Rezum: A Novel Minimally Invasive Therapy for Benign Prostatic Hyperplasia (BPH)"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Raheel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskarn","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Gashaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roocha","family":"Odedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni J","family":"Bochinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Lower urinary tract symptoms in men. (2023). Accessed. 2025: https:\/\/patient.info\/mens-health\/prostate-and-urethra-problems\/lower-urinary-tract-symptoms-in-men."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06097.x","article-title":"The natural history of benign prostatic hyperplasia","volume":"97 Suppl 2","author":"Fitzpatrick JM","year":"2006","unstructured":"Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int. 2006, 97 Suppl 2:3-6; discussion 21-2. 10.1111\/j.1464-410X.2006.06097.x","journal-title":"BJU Int"},{"key":"ref3","article-title":"Benign prostatic hyperplasia: epidemiology, economics and evaluation","volume":"22 Suppl 1","author":"Vuichoud C","year":"2015","unstructured":"Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015, 22 Suppl 1:1-6.","journal-title":"Can J Urol"},{"key":"ref4","unstructured":"Management of non-neurogenic male LUTS. (2022). Accessed. 2025: https:\/\/uroweb.org\/guidelines\/management-of-non-neurogenic-male-luts."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2012.127","article-title":"Relationship between age and prostate size","volume":"15","author":"Zhang SJ","year":"2013","unstructured":"Zhang SJ, Qian HN, Zhao Y, et al.. Relationship between age and prostate size. Asian J Androl. 2013, 15:116-20. 10.1038\/aja.2012.127","journal-title":"Asian J Androl"},{"key":"ref6","article-title":"An assessment of the diagnosed prevalence of diseases in men 50 years of age or older","volume":"12","author":"Issa MM","year":"2006","unstructured":"Issa MM, Fenter TC, Black L, Grogg AL, Kruep EJ. An assessment of the diagnosed prevalence of diseases in men 50 years of age or older. Am J Manag Care. 2006, 12:S83-9.","journal-title":"Am J Manag Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06628-8","article-title":"The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"7","author":"Lee SW","year":"2017","unstructured":"Lee SW, Chan EM, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep. 2017, 7:7984. 10.1038\/s41598-017-06628-8","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1756287218793084","article-title":"Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia","volume":"10","author":"Westwood J","year":"2018","unstructured":"Westwood J, Geraghty R, Jones P, Rai BP, Somani BK. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol. 2018, 10:327-33. 10.1177\/1756287218793084","journal-title":"Ther Adv Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.07.005","article-title":"Emerging minimally invasive treatment options for male lower urinary tract symptoms","volume":"72","author":"Magistro G","year":"2017","unstructured":"Magistro G, Chapple CR, Elhilali M, et al.. Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol. 2017, 72:986-97. 10.1016\/j.eururo.2017.07.005","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/end.2022.0305","article-title":"Transurethral resection of prostate","volume":"36","author":"Agrawal MS","year":"2022","unstructured":"Agrawal MS, Mishra DK. Transurethral resection of prostate. J Endourol. 2022, 36:S29-34. 10.1089\/end.2022.0305","journal-title":"J Endourol"},{"key":"ref11","article-title":"EAU Guidelines on Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS), Incl. Benign Prostatic Obstruction (BPO)","author":"Gravas S","year":"2022","unstructured":"Gravas S, Cornu JN, Gacci M, et al.. EAU Guidelines on Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS), Incl. Benign Prostatic Obstruction (BPO). European Association of Urology, Amsterdam, The Netherlands; 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"67","author":"Gratzke C","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, et al.. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015, 67:1099-109. 10.1016\/j.eururo.2014.12.038","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6051.21.04530-4","article-title":"Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications","volume":"74","author":"Manfredi C","year":"2022","unstructured":"Manfredi C, Arcaniolo D, Spatafora P, et al.. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. 2022, 74:389-99. 10.23736\/S2724-6051.21.04530-4","journal-title":"Minerva Urol Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary KT","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, et al.. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021, 206:715-24. 10.1097\/JU.0000000000001778","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.05.048","article-title":"Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline","volume":"200","author":"Foster HE","year":"2018","unstructured":"Foster HE, Barry MJ, Dahm P, et al.. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018, 200:612-9. 10.1016\/j.juro.2018.05.048","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S119596","article-title":"Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia","volume":"8","author":"Dixon CM","year":"2016","unstructured":"Dixon CM, Cedano ER, Pacik D, et al.. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016, 8:207-16. 10.2147\/RRU.S119596","journal-title":"Res Rep Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.12.045","article-title":"Convective thermal therapy: Durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"197","author":"Roehrborn CG","year":"2017","unstructured":"Roehrborn CG, Gange SN, Gittelman MC, et al.. Convective thermal therapy: Durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 2017, 197:1507-16. 10.1016\/j.juro.2016.12.045","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279883","article-title":"Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: a retrospective single-centre analysis from a German high-volume centre","volume":"18","author":"Winkler T","year":"2023","unstructured":"Winkler T, von Klot CA, Madersbacher S, Kuczyk MA, Wolters M. Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: a retrospective single-centre analysis from a German high-volume centre. PLoS One. 2023, 18:e0279883. 10.1371\/journal.pone.0279883","journal-title":"PLoS One"},{"key":"ref19","unstructured":"International Prostate Symptom Score (IPSS). (2020). Accessed. 2025: https:\/\/urologicspecialistsofne.com\/wp-content\/uploads\/2023\/06\/MA00075-05-Rev-F-Artwork-IPSS-Drug-Satisfaction-Survey...."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900859","article-title":"The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction","volume":"14","author":"Rhoden EL","year":"2002","unstructured":"Rhoden EL, Tel\u00f6ken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res. 2002, 14:245-50. 10.1038\/sj.ijir.3900859","journal-title":"Int J Impot Res"},{"key":"ref21","article-title":"Minimally invasive surgical procedures","volume":"2","author":"Ochsner JL","year":"2000","unstructured":"Ochsner JL. Minimally invasive surgical procedures. Ochsner J. 2000, 2:135-6.","journal-title":"Ochsner J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00836-w","article-title":"Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study","volume":"28","author":"Wolters M","year":"2025","unstructured":"Wolters M, Krastel M, Winkler T, et al.. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study. Prostate Cancer Prostatic Dis. 2025, 28:160-6. 10.1038\/s41391-024-00836-w","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary KT","year":"2019","unstructured":"McVary KT, Rogers T, Roehrborn CG. Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019, 126:171-9. 10.1016\/j.urology.2018.12.041","journal-title":"Urology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolvj.2022.100154","article-title":"Expanding indications for Rezum procedure","volume":"14","author":"Cindolo L","year":"2022","unstructured":"Cindolo L, Campobasso D, Ferrari G, Cicione A, De Nunzio C\r\n. Expanding indications for Rezum procedure. Urol Video J. 2022, 14:100154. 10.1016\/j.urolvj.2022.100154","journal-title":"Urol Video J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00703-0","article-title":"Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men","volume":"27","author":"Zhu M","year":"2024","unstructured":"Zhu M, Babar M, Hawks-Ladds N, et al.. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men. Prostate Cancer Prostatic Dis. 2024, 27:109-15. 10.1038\/s41391-023-00703-0","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsxm.2022.01.173","article-title":"159 efficacy, safety, and sexual dysfunction outcomes of water vapor thermal therapy (Rezum) in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: an updated systematic review","volume":"19","author":"Babar M","year":"2022","unstructured":"Babar M, Loloi J, Ciatto M. 159 efficacy, safety, and sexual dysfunction outcomes of water vapor thermal therapy (Rezum) in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: an updated systematic review. J Sex Med. 2022, 19:S82.","journal-title":"J Sex Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2015.05.046","article-title":"Efficacy and safety of Rezum system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"86","author":"Dixon C","year":"2015","unstructured":"Dixon C, Cedano ER, Pacik D, et al.. Efficacy and safety of Rezum system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2015, 86:1042-7. 10.1016\/j.urology.2015.05.046","journal-title":"Urology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4274\/jus.galenos.2022.2022.0053","article-title":"Water vapor thermal therapy (Rezum\u2122) for benign prostate hyperplasia: initial experience from Turkiye","volume":"9","author":"Tuna MB","year":"2022","unstructured":"Tuna MB, Do\u011fanca T, Argun \u00d6B, Pirdal BZ, T\u00fcfek \u0130, Obek C, Kural AR. Water vapor thermal therapy (Rezum\u2122) for benign prostate hyperplasia: initial experience from Turkiye. J Urol Surg. 2022, 9:228-34. 10.4274\/jus.galenos.2022.2022.0053","journal-title":"J Urol Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/20514158241234390","article-title":"Day case Rezum\u2122 water vapour therapy for urinary retention secondary to benign prostatic hyperplasia","volume":"17","author":"Noureldin M","year":"2024","unstructured":"Noureldin M, Alabed Allat O, Elnabarawy R, et al.. Day case Rezum\u2122 water vapour therapy for urinary retention secondary to benign prostatic hyperplasia. J Clin Urol. 2024, 17:2-6. 10.1177\/20514158241234390","journal-title":"J Clin Urol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15203","article-title":"Rezum water vapour therapy: promising early outcomes from the first UK series","volume":"126","author":"Johnston MJ","year":"2020","unstructured":"Johnston MJ, Noureldin M, Abdelmotagly Y, et al.. Rezum water vapour therapy: promising early outcomes from the first UK series. BJU Int. 2020, 126:557-8. 10.1111\/bju.15203","journal-title":"BJU Int"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00462-w","article-title":"Rez\u016bm water vapor therapy in multimorbid patients with urinary retention and catheter dependency","volume":"25","author":"Eredics K","year":"2022","unstructured":"Eredics K, Wehrberger C, Henning A, et al.. Rez\u016bm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis. 2022, 25:302-5. 10.1038\/s41391-021-00462-w","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00644-8","article-title":"Use of a Schelin catheter for analgesia during Rezum treatment of the prostate","volume":"27","author":"Siena G","year":"2024","unstructured":"Siena G, Sessa F, Cindolo L. Use of a Schelin catheter for analgesia during Rezum treatment of the prostate. Prostate Cancer Prostatic Dis. 2024, 27:147-9. 10.1038\/s41391-023-00644-8","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348352-postoperative-outcomes-following-rezum-a-novel-minimally-invasive-therapy-for-benign-prostatic-hyperplasia-bph","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T21:01:51Z","timestamp":1755291711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348352-postoperative-outcomes-following-rezum-a-novel-minimally-invasive-therapy-for-benign-prostatic-hyperplasia-bph"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.90179","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}